Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(2)

Detailed Status

Terminated1
Withdrawn1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

terminated133%
withdrawn133%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
withdrawnnot_applicable

The Effect of Relaxation Response on Provider Burnout

NCT01786499
terminatednot_applicable

Relaxation Response Training for PTSD Prevention in US Military Personnel

NCT01725854
completedphase_3

Integrated Treatment Program for Hypochondriasis in Primary Care Settings

NCT00368212

Clinical Trials (3)

Showing 3 of 3 trials
NCT01786499Not Applicable

The Effect of Relaxation Response on Provider Burnout

Withdrawn
NCT01725854Not Applicable

Relaxation Response Training for PTSD Prevention in US Military Personnel

Terminated
NCT00368212Phase 3

Integrated Treatment Program for Hypochondriasis in Primary Care Settings

Completed

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3